Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29.1M
-
Number of holders
-
150
-
Total 13F shares, excl. options
-
20.9M
-
Shares change
-
-204K
-
Total reported value, excl. options
-
$1.65B
-
Value change
-
-$15.8M
-
Put/Call ratio
-
6.88
-
Number of buys
-
78
-
Number of sells
-
-55
-
Price
-
$79.22
Significant Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q4 2022
170 filings reported holding KRYS - Krystal Biotech, Inc. - COMMON STOCK as of Q4 2022.
Krystal Biotech, Inc. - COMMON STOCK (KRYS) has 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.9M shares
of 29.1M outstanding shares and own 71.87% of the company stock.
Largest 10 shareholders include FMR LLC (2.11M shares), Redmile Group, LLC (1.9M shares), BlackRock Inc. (1.7M shares), Avoro Capital Advisors LLC (1.41M shares), LORD, ABBETT & CO. LLC (1.28M shares), VANGUARD GROUP INC (1.19M shares), STATE STREET CORP (1.04M shares), Frazier Life Sciences Management, L.P. (1M shares), CREDIT SUISSE AG/ (683K shares), and PICTET ASSET MANAGEMENT SA (626K shares).
This table shows the top 150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.